Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatoprotective role of SMOFlipid in short-term parenteral nutrition in pediatric onco-hematology patients
2015-001614-94Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Jul 2015
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of SMOFlipid in cholestasis (2 arms), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Gamma-glutamyltransferase level. Started Jul 2015; status: completed.
02
Drugs
SMOFlipid
03
Conditions
cholestasis
Beyond the preview
Go deeper on 2015-001614-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001614-94.